Educational Intervention for High Blood Sugar
Trial Summary
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. It seems to focus on educational intervention rather than medication changes.
What data supports the effectiveness of the treatment Educational Intervention, PRE-ACT Model, Patient Navigator Model for high blood sugar?
Research shows that patient education programs, like those used for diabetes, can help people manage their condition better by improving their understanding and self-management skills. This suggests that educational interventions could be effective for managing high blood sugar by empowering patients to take control of their health.12345
Is the Educational Intervention for High Blood Sugar safe for humans?
How does the Educational Intervention for High Blood Sugar differ from other treatments?
The Educational Intervention, also known as the PRE-ACT Model or Patient Navigator Model, is unique because it focuses on empowering patients through interactive education and self-management skills rather than just clinical treatment. This approach emphasizes patient involvement and education to improve their ability to manage high blood sugar, which can lead to better long-term outcomes.711121314
What is the purpose of this trial?
The goal of this clinical trial is to increase Type 2 Diabetes Mellitus knowledge and awareness among patients who present to the Emergency Department with hyperglycemia. The main questions it aims to answer are:* How do patients view their risk of developing type 2 diabetes based on their demographics and behaviors?* Does giving patient education increase patient knowledge, leading to healthier behaviors?Researchers will assess if the educational intervention increases diabetes knowledge and positive health behaviors among Emergency Department hyperglycemic patients.Participants will:* Receive the educational packet (intervention) alongside standard Emergency Care.* Take pre-survey at time of Emergency Department visit and post- survey two weeks later.
Research Team
Sara Heinert, PhD, MPH
Principal Investigator
Rutgers Robert Wood Johnson Medical School
Eligibility Criteria
This trial is for English-speaking adults 18 or older who come to the Robert Wood Johnson University Hospital Emergency Department with high blood sugar levels (≥200 mg/dL), whether they've been diagnosed with Type 2 Diabetes Mellitus before or not.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive educational materials on Type 2 Diabetes Mellitus and resources for follow-up care during their Emergency Department visit
Follow-up
Participants complete a post-survey to assess changes in diabetes knowledge and health behaviors
Treatment Details
Interventions
- Educational Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rutgers, The State University of New Jersey
Lead Sponsor